The motion was filed in relation to the Risperdal litigation (March Term 2010, No. 296) and seeks to have the judge force settlements with 77 plaintiffs. “The essence of this dispute is that J&J [Johnson & Johnson] entered into a legally binding settlement agreement for a confidential amount for 77 Plaintiffs in this litigation, but J&J is now reneging on that Settlement,” lawyers argue. They allege Johnson & Johnson determined after the settlement was reached that the settlement was not in its best interest.
According to the motion, there were prior bellwether Risperdal cases that were settled, including Banks v. Janssen Pharmaceuticals, Inc., et al (January Term 2010, No. 00618) and Rolen v. Janssen Pharmaceuticals, Inc., et al., (January Term 2010, No. 00649). Both, along with four other bellwether cases in the same trial pool, were reportedly settled in late 2012 for confidential amounts.
READ MORE RISPERDAL LEGAL NEWS
One of the original lawsuits that was settled, Banks v. Janssen Pharmaceuticals, Inc., et al, was filed by Aron Banks, a man in his early 20s who alleged Risperdal caused him to grow breasts. His lawsuit was settled on the first day of his trial. According to Bloomberg Businessweek (9/10/12), at the time there were approximately 420 lawsuits against Johnson & Johnson and Janssen Pharmaceuticals, with around 130 of those suits claiming young males grew breasts after using Risperdal.